ABCL
AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- AbCellera Biologics Inc. revenue for the quarter ending March 31, 2026 was 8.3 M, a 96.34% increase year-over-year.
- AbCellera Biologics Inc. revenue for the twelve months ending March 31, 2026 was 38.6 M, a 27.01% increase year-over-year.
- AbCellera Biologics Inc. annual revenue for 2025 was 75.1 M, a 160.56% increase from 2024.
- AbCellera Biologics Inc. annual revenue for 2024 was 28.8 M, a 24.17% decrease from 2023.
- AbCellera Biologics Inc. annual revenue for 2023 was 38.0 M, a 92.17% decrease from 2022.
- AbCellera Biologics Inc. annual revenue for 2022 was 485.4 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AbCellera Biologics Inc. Earnings — FAQ
AbCellera Biologics Inc. (ABCL) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's earnings history?
The chart and table above show AbCellera Biologics Inc.'s earnings by year and by quarter, including the growth rate.